Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19
D. Bohan, H. Van Ert, N. Ruggio…·W. Maury
This study identifies PS receptors, including AXL, as facilitators of SARS-CoV-2 infection by enhancing virus entry into human lung cells, suggesting AXL as a therapeutic target for COVID-19.